These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36315398)

  • 21. Elastic priors to dynamically borrow information from historical data in clinical trials.
    Jiang L; Nie L; Yuan Y
    Biometrics; 2023 Mar; 79(1):49-60. PubMed ID: 34437714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bayesian adaptive randomization design incorporating propensity score-matched historical controls.
    Sawamoto R; Oba K; Matsuyama Y
    Pharm Stat; 2022 Sep; 21(5):1074-1089. PubMed ID: 35278032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A practical Bayesian adaptive design incorporating data from historical controls.
    Psioda MA; Soukup M; Ibrahim JG
    Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Robust incorporation of historical information with known type I error rate inflation.
    Calderazzo S; Wiesenfarth M; Kopp-Schneider A
    Biom J; 2024 Jan; 66(1):e2200322. PubMed ID: 38063813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian dose-finding phase I trial design incorporating historical data from a preceding trial.
    Takeda K; Morita S
    Pharm Stat; 2018 Jul; 17(4):372-382. PubMed ID: 29372582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On efficient posterior inference in normalized power prior Bayesian analysis.
    Han Z; Zhang Q; Wang M; Ye K; Chen MH
    Biom J; 2023 Jun; 65(5):e2200194. PubMed ID: 36960489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The scale transformed power prior for use with historical data from a different outcome model.
    Alt EM; Nifong B; Chen X; Psioda MA; Ibrahim JG
    Stat Med; 2023 Jan; 42(1):1-14. PubMed ID: 36318875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach.
    Qi H; Rizopoulos D; van Rosmalen J
    Res Synth Methods; 2023 May; 14(3):396-413. PubMed ID: 36625478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability-nonexchangeability method.
    Daniells L; Mozgunov P; Bedding A; Jaki T
    Stat Med; 2023 Oct; 42(24):4392-4417. PubMed ID: 37614070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methods.
    Bennett M; White S; Best N; Mander A
    Pharm Stat; 2021 May; 20(3):462-484. PubMed ID: 33474798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causal inference for longitudinal data based on historical controls.
    Liu J; Zhang J; Mitchell A; Fang M; Tian L
    J Biopharm Stat; 2023 May; 33(3):289-306. PubMed ID: 36469552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian methods for the analysis of early-phase oncology basket trials with information borrowing across cancer types.
    Jin J; Riviere MK; Luo X; Dong Y
    Stat Med; 2020 Nov; 39(25):3459-3475. PubMed ID: 32717103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
    Feißt M; Krisam J; Kieser M
    Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacometrics enhanced Bayesian borrowing approach to improve clinical trial efficiency: Case of empagliflozin in type 2 diabetes.
    Fayette L; Sailer MO; Perez-Pitarch A
    CPT Pharmacometrics Syst Pharmacol; 2023 Oct; 12(10):1386-1397. PubMed ID: 37644910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modified power prior with multiple historical trials for binary endpoints.
    Banbeta A; van Rosmalen J; Dejardin D; Lesaffre E
    Stat Med; 2019 Mar; 38(7):1147-1169. PubMed ID: 30360016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A frequentist approach to dynamic borrowing.
    Li R; Lin R; Huang J; Tian L; Zhu J
    Biom J; 2023 Oct; 65(7):e2100406. PubMed ID: 37189217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.